REGIONAL AGENCY FOR PUBLIC HEALTH AND SOCIAL WELL-BEING

Their core work

PHA is a Northern Ireland public health authority responsible for health protection, health improvement, and social well-being across the Belfast region. In the EU research context, they bring real-world public health system experience to projects focused on digital health, patient self-care, and the adoption of personalised medicine at regional level. Their contribution centers on translating research innovations into practical health service delivery, particularly for underserved populations and community-based care settings.

What they specialise in

How they've shifted over time

PHA's early H2020 work (2016) focused on practical digital health tools — mobile technologies for stroke patient self-care and building digital literacy among practitioners. By 2018, their focus shifted decisively toward systemic and strategic topics: personalised medicine, regional biomedical clusters, and interregional collaboration under smart specialisation frameworks. This evolution mirrors a move from individual patient-level digital tools to population-level health system transformation.

PHA is moving toward strategic health system redesign around personalised medicine, making them a relevant partner for projects that need a public health authority to pilot or validate precision health approaches at regional scale.

How they like to work

PHA operates exclusively as a participant, never as coordinator — consistent with their role as a public health authority contributing real-world implementation context rather than driving research agendas. They work in large consortia (44 unique partners across just 3 projects), suggesting they join broad, multi-country coordination and support actions. This makes them a dependable, low-maintenance partner who brings practical health system access without competing for project leadership.

Despite only 3 projects, PHA has built a surprisingly wide network of 44 partners across 23 countries, reflecting their involvement in large-scale EU coordination actions. Their reach spans most of Europe, well beyond the UK and Ireland.

What sets them apart

PHA is a working public health authority — not a university or research institute — which means they can offer something most health research partners cannot: direct access to a real regional health system, patient populations, and frontline practitioners. For any project needing to validate personalised medicine, digital health tools, or care delivery models in a live public health setting, PHA provides a genuine implementation environment rather than a simulated one.

Highlights from their portfolio

• SAPHIRE
  Received EUR 411,495 (87% of PHA's total H2020 funding) to work on regional adoption of personalised health — their clearest strategic commitment and largest investment.
• MAGIC
  Focused on mobile-assisted stroke rehabilitation in community settings, showing PHA's hands-on involvement in patient-facing digital health pilots.